Why participate?

Find potential R&D collaborations or assets available for in-licensing/acquisition

Identify partners with research solutions such as high throughput screening tools, clinical research capacity, or animal models

Secure funding from new investors or find licensing partners for your portfolio

Discover new diagnostics, biomarkers, adjuvants, carrier systems or technologies

Who will attend?

The event is open to any organization that provides assets, products, knowledge or technologies that can help advance the infectious diseases pipelines.

The deployment of successful solutions requires the engagement and implication of multiple stakeholders such as:

Business development, licencing, and scouting executives from the biopharma industry

Biotechs focused on infectious diseases

Early stage researchers from academia, incubators, or research foundations

Companies focusing on infectious diseases related diagnostics or biological markers

Tech transfer offices

Companies providing research tools, models or services needed for infectious diseases R&D